Medipharm Labs Corp
TSX:LABS

Watchlist Manager
Medipharm Labs Corp Logo
Medipharm Labs Corp
TSX:LABS
Watchlist
Price: 0.07 CAD Market Closed
Market Cap: 29.1m CAD

Operating Margin
Medipharm Labs Corp

-20.5%
Current
-100%
Average
6.6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-20.5%
=
Operating Profit
-8.8m
/
Revenue
43m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CA
Medipharm Labs Corp
TSX:LABS
29.1m CAD
-21%
US
Eli Lilly and Co
NYSE:LLY
731.4B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
393.8B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
45%
CH
Roche Holding AG
SIX:ROG
205.6B CHF
33%
CH
Novartis AG
SIX:NOVN
180.8B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP
24%
US
Merck & Co Inc
NYSE:MRK
201.2B USD
34%
IE
Endo International PLC
LSE:0Y5F
183.8B USD
11%
US
Pfizer Inc
NYSE:PFE
139.1B USD
27%

Medipharm Labs Corp
Glance View

Market Cap
29.1m CAD
Industry
Pharmaceuticals

MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.

LABS Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-20.5%
=
Operating Profit
-8.8m
/
Revenue
43m
What is the Operating Margin of Medipharm Labs Corp?

Based on Medipharm Labs Corp's most recent financial statements, the company has Operating Margin of -20.5%.

Back to Top